Table 1.
Summary of the outcome of in vivo chemopreventive studies conducted with silymarin and silibinin against cancers of different organs/sites
Cancer site | Outcome with Silymarin | Outcome with Silibinin |
---|---|---|
Skin Cancer (NMSC) | Positive | Positive |
Prostate Cancer | Positive | Positive |
Breast Cancer | Negative | ND |
Colon Cancer | Positive | ND |
Lung Cancer | ND | Positive/No Effect |
Bladder | Positive | ND |
Ovarian Cancer | ND | Positive |
Hepatocellular Carcinoma | Positive | ND |
Pancreatic Cancer | ND | ND |
ND: Not Determined.